In Vitro Inhibition of Alphaviruses by Lycorine

11Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus. As an emerging virus, CHIKV imposes a threat to public health. Currently, there are no vaccines or antivirals available for the prevention of CHIKV infection. Lycorine, an alkaloid from Amaryllidaceae plants, has antiviral activity against a number of viruses such as coronavirus, flavivirus and enterovirus. In this study, we found that lycorine could inhibit CHIKV in cell culture at a concentration of 10 μmol/L without apparent cytotoxicity. In addition, it exhibited broad-spectrum anti-alphavirus activity, including Sindbis virus (SINV), Semliki Forest virus (SFV), and Venezuelan equine encephalomyelitis virus (VEEV). The time of addition studies indicated that lycorine functions at an early post-entry stage of CHIKV life cycle. The results based on two different CHIKV replicons provided further evidence that lycorine exerts its antiviral activity mainly by inhibiting CHIKV translation. Overall, our study extends the antiviral spectrum of lycorine.

Cite

CITATION STYLE

APA

Li, N., Wang, Z., Wang, R., Zhang, Z. R., Zhang, Y. N., Deng, C. L., … Ye, H. Q. (2021). In Vitro Inhibition of Alphaviruses by Lycorine. Virologica Sinica, 36(6), 1465–1474. https://doi.org/10.1007/s12250-021-00438-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free